TIMOLOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Timolol, and when can generic versions of Timolol launch?
Timolol is a drug marketed by Epic Pharma Llc, Alembic, Amneal, Dr Reddys, Eugia Pharma, Gland Pharma Ltd, Sandoz, Somerset Theraps Llc, Amring Pharms, Apotex, Apotex Inc, Bausch And Lomb, Caplin, Fdc Ltd, Fougera, Hikma, Ingenus Pharms Llc, Mankind Pharma, Micro Labs, Pacific Pharma, Sciegen Pharms Inc, Sentiss Pharma, Somerset, Ani Pharms, Chartwell Rx, Mylan, Quantum Pharmics, Rising, Teva, Usl Pharma, and Watson Labs. and is included in fifty-five NDAs.
The generic ingredient in TIMOLOL is timolol maleate. There are fifteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the timolol maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Timolol
A generic version of TIMOLOL was approved as timolol maleate by MYLAN on June 8th, 1990.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TIMOLOL?
- What are the global sales for TIMOLOL?
- What is Average Wholesale Price for TIMOLOL?
Summary for TIMOLOL
| US Patents: | 0 |
| Applicants: | 31 |
| NDAs: | 55 |
| Raw Ingredient (Bulk) Api Vendors: | 33 |
| Clinical Trials: | 243 |
| Patent Applications: | 7,822 |
| Drug Prices: | Drug price information for TIMOLOL |
| Drug Sales Revenues: | Drug sales revenues for TIMOLOL |
| DailyMed Link: | TIMOLOL at DailyMed |
Recent Clinical Trials for TIMOLOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Kukje Pharma | Phase 2 |
| SpyGlass Pharma, Inc. | Phase 1/Phase 2 |
| D. Western Therapeutics Institute, Inc. | Phase 2 |
Medical Subject Heading (MeSH) Categories for TIMOLOL
Anatomical Therapeutic Chemical (ATC) Classes for TIMOLOL
US Patents and Regulatory Information for TIMOLOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | TIMOLOL MALEATE | timolol maleate | TABLET;ORAL | 072271-001 | Apr 11, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pacific Pharma | TIMOLOL MALEATE | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 074747-001 | Mar 25, 1997 | AT1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | TIMOLOL MALEATE | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 075163-001 | Sep 10, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ani Pharms | TIMOLOL MALEATE | timolol maleate | TABLET;ORAL | 072917-001 | Jul 31, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Quantum Pharmics | TIMOLOL MALEATE | timolol maleate | TABLET;ORAL | 072468-001 | May 19, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sentiss Pharma | TIMOLOL MALEATE | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 217195-001 | May 8, 2023 | AT3 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
